Stock Scorecard
Stock Summary for Geron Corp (GERN) - $1.55 as of 4/28/2026 9:34:12 AM EST
Total Score
9 out of 30
Safety Score
14 out of 100
Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for GERN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for GERN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for GERN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for GERN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for GERN (14 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for GERN
Financial Details for GERN
Company Overview |
|
|---|---|
| Ticker | GERN |
| Company Name | Geron Corp |
| Country | N/A |
| Description | Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 5/6/2026 |
Stock Price History |
|
| Last Day Price | 1.55 |
| Price 4 Years Ago | 2.42 |
| Last Day Price Updated | 4/28/2026 9:34:12 AM EST |
| Last Day Volume | 12,931,535 |
| Average Daily Volume | 19,207,304 |
| 52-Week High | 2.01 |
| 52-Week Low | 1.04 |
| Last Price to 52 Week Low | 49.04% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 38.00 |
| Sector PE | 104.92 |
| 5-Year Average PE | -7.90 |
| Free Cash Flow Ratio | 12.92 |
| Industry Free Cash Flow Ratio | 17.56 |
| Sector Free Cash Flow Ratio | 27.35 |
| Current Ratio Most Recent Quarter | 4.66 |
| Total Cash Per Share | 0.12 |
| Book Value Per Share Most Recent Quarter | 0.35 |
| Price to Book Ratio | 4.43 |
| Industry Price to Book Ratio | 5.92 |
| Sector Price to Book Ratio | 10.48 |
| Price to Sales Ratio Twelve Trailing Months | 5.23 |
| Industry Price to Sales Ratio Twelve Trailing Months | 8.76 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.13 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 640,900,000 |
| Market Capitalization | 993,395,000 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 7.75% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 50.86% |
| Reported EPS 12 Trailing Months | -0.13 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -0.10 |
| Net Income Twelve Trailing Months | -85,782,000 |
| Net Income Past Year | -85,782,000 |
| Net Income Prior Year | -174,572,000 |
| Quarterly Revenue Growth YOY | 1.00% |
| 5-Year Revenue Growth | 273.49% |
| Operating Margin Twelve Trailing Months | -17.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 79,440,000 |
| Total Cash Past Year | 79,440,000 |
| Total Cash Prior Year | 79,016,000 |
| Net Cash Position Most Recent Quarter | -40,107,000 |
| Net Cash Position Past Year | -40,107,000 |
| Long Term Debt Past Year | 119,547,000 |
| Long Term Debt Prior Year | 118,476,000 |
| Total Debt Most Recent Quarter | 119,547,000 |
| Equity to Debt Ratio Past Year | 0.65 |
| Equity to Debt Ratio Most Recent Quarter | 0.65 |
| Total Stockholder Equity Past Year | 225,872,000 |
| Total Stockholder Equity Prior Year | 280,320,000 |
| Total Stockholder Equity Most Recent Quarter | 225,872,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -111,296,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.17 |
| Free Cash Flow Past Year | -111,086,000 |
| Free Cash Flow Prior Year | -219,298,000 |
Options |
|
| Put/Call Ratio | 0.29 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 1.20 |
| 20-Day Bollinger Middle Band | 1.51 |
| 20-Day Bollinger Upper Band | 1.82 |
| Beta | 0.67 |
| RSI | 0.00 |
| 50-Day SMA | 1.39 |
| 150-Day SMA | 2.49 |
| 200-Day SMA | 2.49 |
System |
|
| Modified | 4/24/2026 11:58:29 PM EST |